Universal screening for HCV infection in China: An effectiveness and cost-effectiveness analysis
Background & Aims: Approximately 10 million people live with chronic HCV infection in China, and less than 20% of people with HCV were diagnosed. We aim to determine the cost-effectiveness of one-time HCV screening compared with no screening in the Chinese population from the healthcare syst...
Main Authors: | Hua Zhou, Mengxia Yan, Datian Che, Bin Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-04-01
|
Series: | JHEP Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589555924000016 |
Similar Items
-
Economic evaluation of HCV testing approaches in low and middle income countries
by: Jake R. Morgan, et al.
Published: (2017-11-01) -
Elimination of hepatitis C virus in Germany: modelling the cost-effectiveness of HCV screening strategies
by: Christian Krauth, et al.
Published: (2019-12-01) -
Cost-effectiveness of chronic hepatitis C screening and treatment
by: Hye Won Lee, et al.
Published: (2022-04-01) -
HCV and HBV prevalence based on home blood self-sampling and screening history in the general population in 2016: contribution to the new French screening strategy
by: Cécile Brouard, et al.
Published: (2019-10-01) -
Community-based screening by Anti-HCV reflex HCV Ag test and accessible post-screening care toward elimination of hepatitis C in two hyperendemic townships
by: Kwong-Ming Kee, et al.
Published: (2022-09-01)